Theodoric Meyer covers the Senate for The Washington Post. He was previously a national political reporter and a co-author of the Early Brief, The Post's flagship political newsletter. He joined ...
Jazz Pharmaceuticals plc has a 52-week low of $99.06 and a 52-week high of $148.06. The company has a debt-to-equity ratio of 1.46, a quick ratio of 3.74 and a current ratio of 4.26.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Dane County Judge Susan Crawford recounts her ascent toward ... College friend Jennifer Hanson Meyer described Crawford as a good academic role model who was also kind to a fellow student that ...
This pol’s endorsement could pack some bite. Brooklyn Councilwoman Susan Zhuang, who was charged with chomping on a cop at a raucous anti-homeless shelter rally in July, has announced she is ...
The New Orleans Jazz & Heritage Festival on Tuesday released the daily lineups for its 2025 edition and put single-day tickets on sale. The festival returns to the New Orleans Fair Grounds on ...
The Delaware Supreme Court sided with Gov. Matt Meyer in his fight with state Senate leaders over nominees to the Port of Wilmington. Meyer and Senate Democrats were at odds over whether Meyer could ...
Delaware Gov. Matt Meyer signs his first executive order, creating a youth apprenticeship program, backstage after his inauguration at Delaware State University. (Emma Lee/WHYY) From Philly and the Pa ...
All About Jazz is saddened to learn of the passing of Susan Alcorn--pedal steel guitarist extraordinaire. She died on January 31st of natural causes. Perhaps more than any other pedal steel guitarist ...
Jazz Pharmaceuticals has a 52 week low of $99.06 and a 52 week high of $148.06. The company has a quick ratio of 3.74, a current ratio of 4.26 and a debt-to-equity ratio of 1.46. Insider Activity ...
UBS upgraded Jazz Pharmaceuticals (JAZZ) to Buy from Neutral with a price target of $179, up from $145. The company’s base business strength and Ziihera pipeline catalysts boost confidence that ...